Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Hepatocellular carcinoma (HCC) as the major histological subtype of primary liver cancer remains one of the most common malignancies worldwide. Due to the complicated molecular pathogenesis of HCC, the option for effective systemic treatment is quite limited. There exists a critical need to explore and evaluate possible alternative strategies for effective control of HCC. With a long history of clinical use, Chinese herbal medicine (CHM) is emerging as a noticeable choice for its multi-level, multi-target and coordinated intervention effects against HCC. With the aids of phytochemistry and molecular biological approaches, in the past decades many CHM-derived compounds have been carefully studied through both preclinical and clinical researches and have shown great potential in novel anti-HCC natural product development. The present review aimed at providing the most recent developments on anti-HCC compounds derived from CHM, especially their underlying pharmacological mechanisms.MATERIALS AND METHODS: A systematic search of anti-HCC compounds from CHM was carried out focusing on literatures published both in English (PubMed, Scopus, Web of Science and Medline) and in Chinese academic databases (Wanfang and CNKI database).RESULTS: In this review, we tried to give a timely and comprehensive update about the anti-HCC effects and targets of several representative CHM-derived compounds, namely curcumin, resveratrol, silibinin, berberine, quercetin, tanshinone II-A and celastrol. Their mechanisms of anti-HCC behaviors, potential side effects or toxicity and future research directions were discussed.CONCLUSION: Herbal compounds derived from CHM are of much significance in devising new drugs and providing unique ideas for the war against HCC. We propose that these breakthrough findings may have important implications for targeted-HCC therapy and modernization of CHM.

The recent progresses of anti-cancer fungal extracts

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Plant extract anti-cancer research progress

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations

Research Advance on Anti-tumor Effects and Mechanisms of Traditional Chinese Medicine

Current Advancements in Antitumor Properties and Mechanisms of Medicinal Components in Edible Mushrooms

Repurposing antifungal drugs for cancer therapy.

The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment

A review about the development of fucoidan in antitumor activity: Progress and challenges

Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma

Recent Advances In Anti-Angiogenic Nanomedicines For Cancer Therapy

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

Recent research progress of anti-tumor mechnism matrine

Recent trends in anti-cancer activities of terrestrial plants-based polysaccharides: A review

The advancements and prospective developments in anti-tumor targeted therapy

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

Review of Antitumor Activities of Zangyinchen Extracts and Their Mechanisms

Anti-tumor activity of beauvericin: focus on intracellular signaling pathways

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities